Subcutaneous Mycoses (Mycetoma, Sporotrichosis, Chromoblastomycosis)

Shared Pattern

Saprophytic soil/plant organisms → human disease via TRAUMATIC INOCULATION (thorn, splinter, minor injury, outdoor/agricultural work). Stays LOCALIZED at inoculation site (usually limb), slow progression (months-years), RARELY disseminates (no bloodstream route like inhaled systemic mycosis spores).

Mycetoma

Triad: localized swelling + multiple discharging sinus tracts + GRAINS (organism aggregates in discharge, analogous to actinomycosis sulfur granules).

Old name: “Madura foot” (India).

TWO organism classes (KEY distinction — determines treatment):

• Eumycetoma (TRUE FUNGAL): Madurella mycetomatis classic. BLACK/dark grains.
• Actinomycetoma (BACTERIAL, despite name): Nocardia, Actinomadura, Streptomyces (see Actinomycosis/Nocardiosis topic). PALER grains (white/yellow/red).

Eumycetoma → ANTIFUNGAL drugs. Actinomycetoma → ANTIBACTERIAL drugs. Neither drug class works on the other.

Clinical: FOOT = commonest site (barefoot agricultural work). Years progression, swelling+sinus tracts+grain discharge, untreated → deep muscle/bone invasion → severe deformity.

Diagnosis: Direct exam of grains — Eumycetoma = broad septate fungal hyphae. Actinomycetoma = fine thin branching bacterial filaments. Culture confirms (slow). FNAC + imaging (US grain pattern, MRI extent) support.

Treatment: Actinomycetoma — prolonged combo antibacterial (sulfonamides, amikacin, rifampicin depending on organism), RESPONDS WELL. Eumycetoma — HARDER to treat. Itraconazole (mainstay), slower/less reliable response. Surgery (±amputation advanced) often needed.

Sporotrichosis

Sporothrix schenckii, dimorphic. Traumatic inoculation (thorns, splinters, plants). “ROSE GARDENER’S DISEASE.”

Clinical: LYMPHOCUTANEOUS pattern (classic) — painless nodule at inoculation site (finger/hand) → ulcerates + new nodules appear PROXIMALLY along lymphatic drainage = ASCENDING CHAIN of nodules (near-pathognomonic pattern). Fixed cutaneous (single lesion, no lymphatic spread) also occurs. Disseminated/systemic (bone, joint, pulmonary, rare meningeal) = RARE, essentially immunocompromised only.

Diagnosis: Culture (SDA) = gold standard (low tissue organism numbers, direct microscopy insensitive). Treatment: Itraconazole, months, effective lymphocutaneous+fixed cutaneous. Saturated KI solution = older alternative, resource-limited settings.

Chromoblastomycosis

Dematiaceous (pigmented) fungi, chiefly Fonsecaea pedrosoi. Traumatic inoculation, typically LOWER LIMB.

DIAGNOSTIC HALLMARK: SCLEROTIC BODY (Medlar body/muriform cell) — thick-walled, golden-brown, cross-septated (multi-plane septa, “copper penny” appearance). PATHOGNOMONIC on its own.

Clinical: slow (years-decades). Small papule → VERRUCOUS (wart-like), crusted, cauliflower-like plaque. Untreated: extensive lesions, chronic lymphedema/elephantiasis-like changes, secondary bacterial infection, RARE malignant transformation (SCC) in very long-standing lesion.

Treatment: NOTORIOUSLY DIFFICULT to cure. Itraconazole ± terbinafine, slow/incomplete response common. Adjunct: cryotherapy, local heat therapy, surgical excision (smaller/earlier lesions).

The Shared Pattern: Traumatic Inoculation

Subcutaneous mycoses share a single defining mechanism that distinguishes them from every other fungal disease category — they are caused by ordinarily saprophytic, soil- or plant-dwelling organisms that only cause human disease after traumatic inoculation directly into the subcutaneous tissue, typically via a thorn prick, splinter, or other minor penetrating injury during outdoor/agricultural work. This mechanism explains their entire clinical pattern: infection stays localized near the inoculation site (usually a limb, since that’s what contacts vegetation/soil during work), progresses slowly over months to years, and — unlike the systemic mycoses — rarely disseminates to distant organs, since the organism never gets a route into the bloodstream the way an inhaled systemic-mycosis spore does.

Mycetoma

Definition and the Bacterial/Fungal Split

Mycetoma is a chronic, slowly progressive, deforming infection presenting with a defining clinical triad — localized swelling, multiple discharging sinus tracts, and grains (visible macroscopic particles in the discharge, representing dense aggregates of the causative organism, analogous to the sulfur granules of actinomycosis). Despite the name’s fungal-sounding root, mycetoma is caused by two entirely different organism classes, distinguishable clinically mainly by the colour and consistency of the grains and confirmed by direct examination:

• Eumycetoma (true fungal cause) — most classically Madurella mycetomatis (hence mycetoma’s older name, “Madura foot,” after the Indian region where it was first well described), producing black or dark grains.
• Actinomycetoma (bacterial cause, despite the name) — caused by aerobic actinomycetes, chiefly Nocardia, Actinomadura, and Streptomyces species (see Actinomycosis and Nocardiosis for Nocardia’s other disease forms), producing paler (white, yellow, or red, depending on species) grains.

This distinction is not academic — it is the single most important branch point in management, since eumycetoma responds to antifungal drugs and actinomycetoma to antibacterial drugs, and neither class of drug works against the other’s causative organism.

Clinical Manifestations

The foot is overwhelmingly the commonest site (consistent with barefoot agricultural work being the dominant risk exposure), though any exposed limb can be affected. Disease progresses over years, with progressive tissue swelling, multiple sinus tracts opening onto the skin surface discharging pus containing the characteristic grains, and, without treatment, eventual deep invasion into muscle and even bone, producing severe deformity and functional loss — mycetoma is a genuinely disabling disease specifically because of how long it’s typically left untreated in resource-limited settings before diagnosis.

Laboratory Diagnosis

Direct examination of expressed grains (crushed and mounted, or on histopathology) is the fastest way to make the eumycetoma/actinomycetoma distinction: eumycetoma grains show broad, septate fungal hyphae; actinomycetoma grains show fine, thin, branching bacterial filaments. Culture confirms species identification but is slow. Fine-needle aspiration cytology and imaging (ultrasound showing the characteristic grain pattern, MRI for extent) support diagnosis and surgical planning.

Treatment

Actinomycetoma responds well to prolonged combination antibacterial therapy (regimens built around sulfonamides, amikacin, or rifampicin, depending on the specific organism). Eumycetoma is considerably harder to treat — response to antifungal therapy (itraconazole being the mainstay) is slower and less reliable, and surgical excision (sometimes amputation in advanced, deeply invasive disease) is frequently needed alongside or instead of medical therapy alone.

Sporotrichosis

The Organism and “Rose Gardener’s Disease”

Caused by the dimorphic fungus Sporothrix schenckii, acquired by traumatic inoculation from thorns, splinters, or contaminated plant material — classically associated with rose-growing and other gardening/horticultural work, giving it the nickname “rose gardener’s disease.”

Clinical Manifestations

The classic pattern is lymphocutaneous sporotrichosis: a painless nodule develops at the inoculation site (usually a finger or hand) and, over subsequent weeks, ulcerates while new nodules appear in a line proximally along the draining lymphatic channel — a distinctive ascending chain of nodules tracking the lymphatic drainage route, which is a genuinely useful, near-pathognomonic clinical pattern once recognized. Fixed cutaneous disease (a single lesion without lymphatic spread) also occurs. Disseminated or systemic sporotrichosis (bone, joint, pulmonary, or rarely meningeal involvement) is rare and essentially confined to the immunocompromised.

Laboratory Diagnosis and Treatment

Culture on SDA remains the diagnostic gold standard, given the organism’s low numbers in tissue (making direct microscopy relatively insensitive). Treatment is itraconazole, given for months, which is effective for both lymphocutaneous and fixed cutaneous disease; saturated potassium iodide solution is an older, still-occasionally-used alternative in resource-limited settings.

Chromoblastomycosis

The Organism and Diagnostic Hallmark

Caused by several dematiaceous (naturally pigmented, dark-walled) fungi — chiefly Fonsecaea pedrosoi and related genera — again acquired by traumatic inoculation, typically on the lower limb. The disease’s diagnostic hallmark, seen on direct microscopy or histopathology of affected tissue, is the sclerotic body (also called a Medlar body or muriform cell) — a distinctive, thick-walled, golden-brown, cross-septated (divided by septa in multiple planes, giving a “copper penny” appearance) fungal cell, pathognomonic enough that finding it essentially confirms the diagnosis on its own.

Clinical Manifestations

Slowly progressive, over years to decades, beginning as a small papule at the inoculation site and evolving into a verrucous (wart-like), crusted, cauliflower-like plaque — the chronic, warty surface texture being the disease’s other clinically distinctive feature alongside its glacial pace. Untreated, lesions can become extensive, and chronic lymphoedema/elephantiasis-like changes can develop from long-standing lymphatic obstruction; secondary bacterial infection and, rarely, malignant transformation (squamous cell carcinoma) within a very long-standing lesion are recognized complications.

Treatment

Notoriously difficult to cure — response to antifungal therapy (itraconazole, sometimes combined with terbinafine) is slow and incomplete in a meaningful proportion of cases, and adjunctive physical measures (cryotherapy, local heat therapy, or surgical excision for smaller, earlier lesions) are often needed alongside prolonged systemic antifungal treatment.

Short Essays (3)

Short Answers (2)

Short Notes (7)

Multiple Choice Questions (4)